Steven Nurkin, MD, MS

PrintE-mail
Assistant Professor of Oncology
Roswell Park Cancer Institute

Profile

Areas of Expertise: 
Laparoscopic and Robotic Gastrointestinal Surgery
Endoscopic Resection of Tumors
Surgical Education
The Use of a IT and Mobile “App” Technology to Improve Patient Care

Background Information

Education and Training: 
Technion Faculty of Medicine, Haifa, Israel
Residency: 
General Surgery Resident, New York Hospital Queens / New York Presbyterian Hospital, Flushing, NY
Chief Surgical Resident, New York Hospital Queens / New York Presbyterian Hospital, Flushing, NY
Board Certification: 
American Board of Surgery
Fellowships: 
Surgical Oncology Fellow, Roswell Park Cancer Institute, Buffalo, NY

Publications

Publications: 
  • Malik NK, Patil S, Groman A, Nava H, Yendamuri S, Nurkin S, Sher T, Warren G, Yang G, May K. Outcomes in Patients 65 Years or Older Treated with Trimodality Therapy for Esophageal Carcinoma. International journal of radiation oncology, biology, physics 2011; 81(2 Suppl.):S312
  • Nurkin SJ, Kane JM 3rd. Margin status, local recurrence, and survival: correlation or causation?. Surgical oncology clinics of North America 2012; 21(2):255-267
  • Nurkin S, Nava HR, Yendamuri S, Levea CM, Nwogu C, Wilding G, Khushalani N. Outcomes of Endoscopic Resection for High Grade Dysplasia and Esophageal Cancer. Gastrointestinal endoscopy 2012; 75(4 Suppl.):473
  • Platz TA, Nurkin SJ, Fong MK, Malhotra U, Yendamuri SS, Nava HR, Warren GWr, Salerno MK. Neoadjuvant carboplatin/paclitaxel with concurrent radiotherapy followed by surgery for esophageal/gastroesophageal junction adenocarcinoma: A single-institution experience. Journal of clinical oncology 2012; 30(15 Suppl.):Abstract #e14712